POZIKIDS: Exercise and Comprehensive Care to Improve the Quality of Life of Children and Adolescents With Cancer
PoziKids
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
Objective: To assess the feasibility of a supervised, controlled and personalised physical exercise programme and its potential efficacy in improving functional capacity and quality of life in children and adolescents with cancer. Design: Hybrid quasi-experimental pilot trial, clinical and phase I implementation. Methods: The learning collaborative approach based on the Institute for Healthcare Improvement Breakthrough Series Collaborative Model will be followed through quarterly Plan-Do-Study-Act (P-D-S-A) cycles. Participants: For feasibility, at least, 45 patients will be included in 3 successive PDSA cycles of at least 15 patients each, aged 4-18 years diagnosed with any type of cancer. Variables: clinical and socio-demographic, body composition, physical condition and mobility, quality of life, physical activity and implementation. Intervention: Everyone will receive a physical exercise intervention combining strength and aerobic capacity work. Initially it will be carried out in the hospital setting, and later in streaming supervised by a professional. The intervention will be modelled through a formative evaluation process with the collaboration of all the agents involved, experimenting in each cycle with an increasingly adapted version of the exercise programme. Statistical analysis: Recruitment rates will be calculated, characteristics associated with project participation and adherence to the exercise programme will be identified. Outcome variables will be compared before and after the intervention, identifying those with the greatest validity, reliability and sensitivity to change, which will then be used in phase II and III trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
March 20, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
August 20, 2024
August 1, 2024
1.6 years
February 6, 2024
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (11)
Quarterly recruitment rates assessed by comparing those who participate with those who do not.
To assess the feasibility of the exercise programme, quarterly recruitment rates will be calculated over the recruitment and follow-up period, and socio-demographic and morbidity variables associated with study participation will be identified, comparing those who participate with those who do not, using logistic regression analysis.
2 years
Adherence rates assessed by the proportion of sessions completed and adherence to the prescribed exercise protocol
Participants' adherence to the programme will be described in terms of the proportion of sessions completed and compliance with the exercise protocol prescribed for each patient, and variables associated with compliance will be identified.
2 years
Body composition assessed by the Body Mass Index
Body Mass Index (BMI): Diagnoses and classifies obesity. weight and height will be combined to report BMI in kg/m\^2). Measured at baseline, and 3 months.
2 years
Muscle mass
Muscle mass will be measured in kgs by a bioimpedance scale. Measured at baseline, and 3 months.
3 months
Bone mineral density
Bone mineral density will be in g/cm2 measured by a bioimpedance scale. Measured at baseline, and 3 months.
3 months
Physical condition assessed by the 6 min walking test and manual grip test with a dynamometer
The 6 minutes walking Test applies to assess functional capacity, as well as a predictor of morbidity and mortality in people with different pathologies. Most of the daily activities that the patients with these pathologies are performed at submaximal exercise intensity, similar to this test is performed. It would be measured at 0 and 3 months.
3 months
Muscular strength assessed by manual grip test with a dynamometer
The manual grip test with a dynamometer applies to assess muscular strength. Most of the daily activities that the patients with these pathologies are performed at submaximal exercise intensity, similar to this test is performed. It would be measured at 0 and 3 months.
3 months
General Quality of life assessed by the PedsQL 4.0 questionnaire
The PedsQL Measurement Model is a modular approach to measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions. The PedsQL Measurement Model integrates seamlessly both generic core scales and disease-specific modules into one measurement system. The questionnaire is self-reported for children over 8 years old and self-reported by parents for children under 8 years old. This questionnaire has been validated in the Spanish population. It would be measured at 0 and 3 months.
3 months
Specific Quality of life assessed by the PedsQL cancer questionnaire
The Pediatric Quality of Life Inventory (PedsQL) Cancer Module is a standard tool designed to assess the HRQOL among pediatric oncology patients. Consists of an instruction section and 27 items, contained in 8 dimensions. This questionnaire has been validated in the Spanish population. It would be measured at 0 and 3 months.
3 months
Fatigue assessed by the PedsQL Multidimensional Fatigue Scale Acute Version (PedsQL-MFS)
The PedsQL™ Multidimensional Fatigue Scale was designed as a generic symptom-specific instrument to measure fatigue in patients with acute and chronic health conditions as well as healthy school and community populations. The appropriate questionnaire will be used depending on the age of the patients (Toddlers (2-4 years of age), Young Child (5-7 years of age), Child (8-12 years of age), Adolescent (13-18 years of age)). This questionnaire has been validated in the Spanish population. It would be measured at 0 and 3 months.
3 months
Physical activity level assessed by accelerometers
Objectively registered with Actigraph wGT3X-BT accelerometer. Measured at 0 and 3 months
3 months
Secondary Outcomes (3)
Security assessment
2 years
Costs associated estimation
3 years
Implementation barriers and facilitators
2 years
Interventions
At least two sessions a week for a 6-month supervised and individualized physical exercise program that will have two phases: one that will be carried out in person in the hospital environment taking advantage of medical visits, and a second phase that will allow the patient to carry out the exercise sessions from home with live virtual supervision.
Two types of intervention are proposed depending on the age of the patients: Exercise intervention for adolescents (12 to 18 years): training will be based on strength training (2 - 3 sets of 8 - 12 repetitions) with elastic bands, weights, weights, medicine balls or body weight and aerobic work on a stationary bike, treadmill or other aerobic exercises. Sessions will last about 30-60 minutes (depending on the patient's situation). Exercise intervention for children (4 to 11 years old): The aim will be to work on basic motor skills through play, thus trying to avoid the delay in motor development, and to indirectly work on their physical condition to better cope with the effects of the treatments. Music, games that require movement and materials such as balls, hoops, etc., will be used to motivate the child to move while enjoying themselves. This will be done in sessions of 20 - 40 minutes.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with cancer and other neoplasms
- Patients diagnosed with cancer and other malignancies aged between 4 and 18 years who are experiencing relapse
- Paediatric patients requiring chemotherapy, radiotherapy, or oncological surgery
- Patients and parents or guardians who agree to participate in the study and sign the informed consent forms by current legislation depending on the patient's age.
You may not qualify if:
- Patients with cognitive deficits that prevent participation in and performance of physical exercise interventions.
- Patients with severe neurological pathology with a motor impairment that prevents or significantly hinders the performance of physical exercise
- Patients and families or guardians with language comprehension difficulties that make it difficult or impossible to carry out the physical exercise intervention.
- Patients \< 16 years with a functional status score according to Lanskyi scale \<60%
- Patients \> 16 years with Karnofsky scale \<60%.
- Any other criteria that the physician deems inappropriate for participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nere Mendizaballead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta Menchaca Torio
Basque Health Service
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Nurse
Study Record Dates
First Submitted
February 6, 2024
First Posted
March 20, 2024
Study Start
November 15, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
August 20, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share